{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:45:20Z","timestamp":1789998320702,"version":"4.0.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.juro.2012.09.123","type":"journal-article","created":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T17:30:31Z","timestamp":1349199031000},"page":"1541-1546","source":"Crossref","is-referenced-by-count":5,"title":["HMGB1 Release by Urothelial Carcinoma Cells is Required for the In Vivo Antitumor Response to Bacillus Calmette-Gu\u00e9rin"],"prefix":"10.1097","volume":"189","author":[{"given":"Guangjian","family":"Zhang","sequence":"first","affiliation":[{"name":"Departments of Urology and Pediatrics (BJ), Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghong","family":"Chen","sequence":"additional","affiliation":[{"name":"Departments of Urology and Pediatrics (BJ), Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Cao","sequence":"additional","affiliation":[{"name":"Departments of Urology and Pediatrics (BJ), Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryon","family":"Johnson","sequence":"additional","affiliation":[{"name":"Departments of Urology and Pediatrics (BJ), Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"See","sequence":"additional","affiliation":[{"name":"Departments of Urology and Pediatrics (BJ), Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.09.123_bib1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.eururo.2011.03.017","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update","volume":"59","author":"Babjuk","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.09.123_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5489\/cuaj.10051","article-title":"Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy","volume":"4","author":"Kassouf","year":"2010","journal-title":"Can J Urol"},{"key":"10.1016\/j.juro.2012.09.123_bib3","series-title":"Guideline for the Management of Non-muscle Invasive Bladder Cancer: (Stages Ta, T1, and Tis): AUA Update 2007","author":"Hall","year":"2007"},{"key":"10.1016\/j.juro.2012.09.123_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.urolonc.2006.07.021","article-title":"Bacillus Calmette-Gu\u00e9rin induces p21 expression in human transitional carcinoma cell lines via an immediate early, p53 independent pathway","volume":"25","author":"Zhang","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2012.09.123_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0022-5347(05)64745-3","article-title":"Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Gu\u00e9rin through nuclear factor-kappaB and Ap-1 via an immediate early pathway","volume":"168","author":"Chen","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.09.123_bib6","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1016\/j.juro.2009.08.018","article-title":"MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin","volume":"182","author":"Chen","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.09.123_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2490-5-8","article-title":"BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking","volume":"5","author":"Chen","year":"2005","journal-title":"BMC Urol"},{"key":"10.1016\/j.juro.2012.09.123_bib8","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.juro.2007.06.040","article-title":"Bacillus Calmette-Guerin inhibits apoptosis in human urothelial carcinoma cell lines in response to cytotoxic injury","volume":"178","author":"Chen","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.09.123_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/08916930701356978","article-title":"HMGB1: a signal of necrosis","volume":"40","author":"Raucci","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/j.juro.2012.09.123_bib10","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1111\/j.1464-410X.2008.08274.x","article-title":"Bacille-Calmette Guerin induces caspase-independent cell death in urothelial carcinoma cells together with release of the necrosis-associated chemokine high molecular group box protein 1","volume":"103","author":"See","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2012.09.123_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mossman","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.juro.2012.09.123_bib12","first-page":"20","article-title":"CpG oligonucleotide therapy cures subcutaneous and orthotopic tumors and evokes protective immunity in murine bladder cancer","volume":"28","author":"Ninalga","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.juro.2012.09.123_bib13","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/1078-0432.CCR-06-1953","article-title":"Masquerader: high mobility group box-1 and cancer","volume":"13","author":"Ellerman","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2012.09.123_bib14","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.192.4.565","article-title":"High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes","volume":"192","author":"Andersson","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.juro.2012.09.123_bib15","first-page":"375","article-title":"High mobility group 1 B-box mediates activation of human endothelium","volume":"254","author":"Treutiger","year":"2003","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.juro.2012.09.123_bib16","first-page":"1","article-title":"Addicted to death: invasive cancer and the immune response to unscheduled cell death","volume":"28","author":"Zeh","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.juro.2012.09.123_bib17","first-page":"1863","article-title":"Amphotericin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer","volume":"10","author":"Kuniyasu","year":"2003","journal-title":"Oncol Rep"},{"key":"10.1016\/j.juro.2012.09.123_bib18","first-page":"4805","article-title":"Receptor for advanced glycation end products-binding COOH-terminal motif of amphotericin inhibits invasive migration and metastasis","volume":"62","author":"Huttunen","year":"2002","journal-title":"J Can Res"},{"key":"10.1016\/j.juro.2012.09.123_bib19","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1073\/pnas.100108697","article-title":"Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin","volume":"97","author":"He","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.juro.2012.09.123_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbagrm.2009.11.014","article-title":"High-mobility group box 1 and cancer","volume":"1799","author":"Tang","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.juro.2012.09.123_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cytogfr.2006.01.003","article-title":"High-mobility group box 1 (HMGB1) protein: friend and foe","volume":"17","author":"Ulloa","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.juro.2012.09.123_bib22","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1189\/jlb.72.6.1084","article-title":"HMGB1 as a DNA-binding cytokine","volume":"72","author":"Andersson","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.juro.2012.09.123_bib23","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.juro.2009.12.008","article-title":"HAMLET treatment delays bladder cancer development","volume":"183","author":"Mossberg","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.09.123_bib24","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.juro.2012.01.030","article-title":"Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Gu\u00e9rin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer","volume":"187","author":"Bockholt","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.09.123_bib25","doi-asserted-by":"crossref","unstructured":"Leite KR, Chade DC and Sanudo A: Effects of curcumin in an orthotopic murine bladder tumor model. Int Braz J Urol 35: 599.","DOI":"10.1590\/S1677-55382009000500012"},{"issue":"suppl","key":"10.1016\/j.juro.2012.09.123_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000474916","article-title":"Role of the immune response in BCG for bladder cancer","volume":"21","author":"Ratliff","year":"1992","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.09.123_bib27","first-page":"350","article-title":"Role of IFN gamma and IL-10 in immunotherapy of bladder cancer with Mycobacterium bovis BCG","volume":"203","author":"Brandau","year":"2000","journal-title":"Immunobiology"},{"key":"10.1016\/j.juro.2012.09.123_bib28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.ju.0000073852.24341.4a","article-title":"Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer","volume":"170","author":"B\u00f6hle","year":"2003","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712051324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712051324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.09.123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T01:39:03Z","timestamp":1687743543000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.09.123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1016\/j.juro.2012.09.123"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.09.123","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}